Current knowledge of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) as a medicinal plant species: a review on the bioactive components, pharmacological properties, analytical and biotechnological studies

Phytochemistry Reviews

Volumn 16, Issue 2, 2017, Pages 195-218

  Szopa, Agnieszka ^a   Ekiert, Radosław ^b   Ekiert, Halina ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Herbapol Krakow SA   (Poland)

Author keywords

Dibenzocyclooctadiene lignans; Gomisin A; In vitro cultures; Schisandrin; Schizandra; Triterpenoids

Indexed keywords

DEOXYSCHISANDRIN; GAMMA SCHISANDRIN; GOMISIN A; LIGNAN DERIVATIVE; SCHISANDRA CHINENSIS EXTRACT; SCHISANDRIN; SCHISANDRIN C; SCHISANTHENOL; SCHISANTHERIN A; SCHISANTHERIN B; SCHIZANDRIN B; UNCLASSIFIED DRUG;

ANTIAGING ACTIVITY; ANTIASTHMATIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOBESITY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BIOMASS; BIOTECHNOLOGY; CAPILLARY ELECTROCHROMATOGRAPHY; CELL PROLIFERATION; CHEMICAL COMPOSITION; DENSITOMETRY; DETOXIFICATION; DRUG ACTIVITY; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; LIMIT OF QUANTITATION; LIVER CELL; LIVER PROTECTION; MASS FRAGMENTOGRAPHY; NONHUMAN; PHYTOCHEMISTRY; REVIEW; REVITALIZING ACTIVITY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; THIN LAYER CHROMATOGRAPHY; TRADITIONAL MEDICINE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84966714519     PISSN: 15687767     EISSN: 1572980X     Source Type: Journal    
DOI: 10.1007/s11101-016-9470-4     Document Type: Review

References (136)

1. Alexander JS, Wang Y (2012) Therapeutic potential of Schisandra chinensis extracts for treatment of hypertension. Hypertens Res 35:892–893
2. Bensky D, Gamble A (1993) Chinese herbal medicine materia medica. Eastland Press, Vista, pp 376–378
3. Blunder M, Pferschy-Wenzig EM, Fabian WM et al (2010) Derivatives of schisandrin with increased inhibitory potential on prostaglandin E2 and leukotriene B4 formation in vitro. Bioorg Med Chem 18:2809–2815
4. Brezinová L, Vlasínová H, Havel L et al (2010) Validated method for bioactive lignans in Schisandra chinensis in vitro cultures using a solid phase extraction and a monolithic column application. Biomed Chromatogr 24:954–960
5. Casarin E, Dall’Acqua S, Smejkal K et al (2014) Molecular mechanisms of antiproliferative effects induced by Schisandra-derived dibenzocyclooctadiene lignans (+)-deoxyschisandrin and (−)-gomisin N in human tumour cell lines. Fitoterapia 98:241–247
6. Chen DF, Zhang SX, Kozuka M et al (2002) Interiotherins C and D, two new lignans from Kadsura interior and antitumor-promoting effects of related neolignans on Epstein-Barr virus activation. J Nat Prod 65:1242–1245
7. 3, and BA on somatic embryo development. Plant Cell Tiss Organ Cult 102:357–364
8. Chen X, Zhang Y, Zu Y et al (2011) Composition and biological activities of the essential oil from Schisandra chinensis obtained by solvent-free microwave extraction. LWT-Food Sci Technol 44:2047–2052
9. Chen Y, Tang J, Wang X et al (2012) An immunostimulatory polysaccharide (SCP-IIa) from the fruit of Schisandra chinensis (Turcz.) Baill. Int J Biol Macromol 50:844–848
10. Chen P, Pang S, Yang N et al (2013a) Beneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction. PLoS One 8:e79418
11. Chen YC, Liaw CC, Cheng YB et al (2013b) Anti-liver fibrotic lignans from the fruits of Schisandra arisanensis and Schisandra sphenanthera. Bioorg Med Chem Lett 23:880–885
12. 2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes. Life Sci 82:1092–1101
13. Chiu PY, Lam PY, Yan CW et al (2011) Schisandrin B protects against solar irradiation-induced oxidative injury in BJ human fibroblasts. Fitoterapia 82:682–691
14. Choi YW, Takamatsu S, Khan SI et al (2006) Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans. J Nat Prod 69:356–359
15. Chu C, Zhang S, Tong S et al (2013) An efficient strategy for the extraction and purification of lignans from Schisandra chinensis by a combination of supercritical fluid extraction and high-speed counter-current chromatography. J Sep Sci 36:3958–3964
16. Chun JN, Cho M, So I et al (2014) The protective effects of Schisandra chinensis fruit extract and its lignans against cardiovascular disease: a review of the molecular mechanisms. Fitoterapia 97:224–233
17. Deng X, Chen X, Cheng W et al (2008) Simultaneous LC-MS quantification of 15 lignans in Schisandra chinensis (Turcz.) Baill. fruit. Chromatographia 67:559–566
18. Dušková J, Dušek J, Jahodár L (1999) Zur Biotransformation von Hydrochinon zu Arbutin in den In Vitro-Kulturen. Herba Pol 45:23–26
19. Dušková J, Dušek J, Jahodár L et al (2005) Arbutin, salicilin: the possibilities of their biotechnological production. Ceska Slov Farm 54:78–81
20. Dweck AC, Marshall N (2009) Much new presented at Munich show. In-Cosmet Rev 6:13–21
21. Ekiert R (2005) Cytryniec-niedoceniany dar chińskiej medycyny. Lek w Polsce 15:88–92
22. Ekiert R, Szopa A, Ekiert H et al (2013) Analysis of lignans in Schisandra chinensis fruits, leaves, biomasses from in vitro cultures and food supplements. J Funct Foods 5:1576–1581
23. European Pharmacopoeia 6.3 (2008) Schisandra fruit. European directorate for the quality of medicines, Strasburg
24. European Pharmacopoeia 8.0 (2013) Schisandra fruit. European directorate for the quality of medicines, Strasburg
25. Fil’kin AM (1952) About Schizandra chinensis (historical-literary information). Aptechnojje Delo 2:46–48
26. Fong WF, Wan CK, Zhu GY et al (2007) Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes. Planta Med 73:212–220
27. Foster S (1998) An ilustred guide. 101 medicinal herbs. Interweave Press, Loveland
28. Garnier S, Msika P (2013) Schisandra sphenanthera fruit extract and cosmetic, dermatological, and nutraceutical compositions comprising same. United States Patent US 8,586,107 B2
29. Genders R (1977) Scented flora of the world. R Hale, London
30. Gnabrea J, Unlua I, Chang T et al (2010) Isolation of lignans from Schisandra chinensis with anti-proliferative activity in human colorectal carcinoma: structure–activity relationships. J Chromatogr B 878:2693–2700
31. Guo Z, Zhao A, Chen T et al (2012) Differentiation of Schisandra chinensis and Schisandra sphenanthera using metabolite profiles based on UPLC-MS and GC-MS. Nat Prod Res 26:255–263
32. Hakala E, Hanski L, Uvell H et al (2015) Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis. J Antibiot 68:609–614
33. Halstead CW, Lee S, Khoo CS et al (2007) Validation of a method for the simultaneous determination of four schisandra lignans in the raw herb and commercial dried aques extracts of Schisandra chinensis (Wu Wei Zi) by RP-LC with DAD. J Pharm Biomed Anal 45:30–37
34. Hancke JL, Burgos RA, Ahumada F (1999) Schisandra chinensis (Turcz.) Baill. Fitoterapia 70:451–471
35. Havel L, Vlašínová H, Bohatcová I et al (2008) Dibenzocyclooctadiene lignan production in Schisandra chinensis embryogenic culture. J Biotechnol 136:402–459
36. He XG, Lian LZ, Lin LZ (1997) Analysis of lignan constituents from Schisandra chinensis by liquid chromatography-electrospray mass spectrometry. J Chromatogr A 757:81–87
37. Henry F, Danoux L, Pauly G (2012) Cosmetic use of an extract of the fruit of Schisandra chinensis. European Patent Specification EP 1,699,475 B1
38. Hou W, Gao W, Wang D et al (2015) The protecting effect of deoxyschisandrin and schisandrin B on HaCaT cells against UVB-induced damage. PLoS One 10:e0127177
39. Hu D, Yang Z, Yao X et al (2014) Dibenzocyclooctadiene lignans from Schisandra chinensis and their inhibitory activity on NO production in lipopolysaccharide-activated microglia cells. Phytochemistry 104:72–78
40. Huang SX, Yang J, Huang H et al (2007) Structural characterization of schintrilactone, a new class of nortriterpenoids from Schisandra chinensis. Org Lett 9:4175–4178
41. Huang SX, Han QB, Lei C et al (2008) Isolation and characterization of miscellaneous terpenoids of Schisandra chinensis. Tetrahedron 64:4260–4267
42. Huang TL, Lin JC, Chyau CC et al (2013) Purification of lignans from Schisandra chinensis fruit by using column fractionation and supercritical antisolvent precipitation. J Chromatogr A 1282:27–37
43. Hwang D, Shin SY, Lee Y et al (2011) A compound isolated from Schisandra chinensis induces apoptosis. Bioorg Med Chem Lett 21:6054–6057
44. Ikeya Y, Taguchi H, Yosioka I et al (1979) The constituents of Schizandra chinensis Baill. Isolation and structure determination of five new lignans: gomisin A, B, C, F and G and the absolute structure of schizandrin. Chem Pharm Bull 27:1383–1394
45. Jeong EJ, Lee HK, Lee KY et al (2013) The effects of lignan-riched extract of Shisandra chinensis on amyloid-β-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse. J Ethnopharm 146:347–354
46. Jiang K, Song QY, Peng SJ et al (2015a) New lignans from the roots of Schisandra sphenanthera. Fitoterapia 103:63–70
47. Jiang Y, Fan X, Wang Y et al (2015b) Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation. Chem Biol Interact 231:83–89
48. Kim TD, Anbazhagan Ramesh V, Park JI (2005) Somatic embryogenesis in Schisandra chinensis (Turcz.) Baill. In vitro Cell Dev Biol Plant 41:253–257
49. Kim SH, Joo MH, Yoo SH (2009) Structural identification and antioxidant properties of major anthocyanin extracted from Omija (Schizandra chinensis) fruit. J Food Sci 74:134–140
50. Kim H, Ahn YT, Kim YS et al (2014a) Antiasthmatic effects of Schizandrae fructus extract in mice with asthma. Pharmacogn Mag 10:80–85
51. Kim YJ, Lee HJ, Kim CY et al (2014b) Simultaneous determination of nine lignans from Schisandra chinensis extract using ultra-performance liquid chromatography with tandem mass spectrometry in rat plasma, urine, and gastrointestinal tract samples: application to the pharmacokinetic study of Schisandra chinensis. J Sep Sci 37:2851–2863
52. Kochetkov NK, Khorlin AY, Chizhov OS et al (1961) Schizandrin-lignan of unusual structure. Tetrahedron Lett 2:730–734
53. Kohda H, Ozaki M, Namera A (2012) Production of lignans in calluses of Schisandra chinensis. J Nat Med 66:373–376
54. Kvasničková L, Glatz Z, Štĕbová H et al (2001) Application of capillary electrochromatography using macroporous polyacrylamide columns for the analysis of lignans from seeds of Schisandra chinensis. J Chromatogr A 916:265–271
55. Lee HJ, Kim CY (2010) Simultaneous determination of nine lignans using pressurized liquid extraction and HPLC-DAD in the fruits of Schizandra chinensis. Food Chem 120:1224–1228
56. Lee IS, Jung KY, Oh SR et al (1999) Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. Biol Pharm Bull 22:265–267
57. Li L, Lu Q, Shen Y et al (2006) Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. Biochem Pharmacol 71:584–595
58. Li B, Meng X, Zhu L et al (2014) Application of high-speed counter-current chromatography for isolation of triterpenes from Schisandra chinensis (Turcz.) Baill and induction apoptosis mechanism of HSC-T6. Biomed Mater Eng 24:969–977
59. Liang CQ, Hu J, Shi YM et al (2013) Schisphenlignans A-E: five new dibenzocyclooctadiene lignans from Schisandra sphenanthera. Chem Pharm Bull 61:96–100
60. Linsmaier EM, Skoog F (1965) Organic growth factor requirements of tobacco tissue cultures. Physiol Plant 18:100–127
61. Liu HW, Yu XZ, Padula D et al (2013) Lignans from Schisandra sphenathera Rehd. et Wils. and semisynthetic schisantherin A analogues: absolute configuration, and their estrogenic and anti-proliferative activity. Eur J Med Chem 59:265–273
62. Lloyd G, McCown B (1980) Commercially-feasible micropropagation of mountain laurel, by use of shoot-tip culture. Comb Proc Int Plant Prop Soc 30:421–427
63. Lu Y, Chen DF (2009) Analysis of Schisandra chinensis and Schisandra sphenanthera. J Chromatogr A 1216:1980–1990
64. Ma C, Yang L, Yang F et al (2012a) Content and color stability of anthocyanins isolated from Schisandra chinensis fruit. Int J Mol Sci 13:14294–14310
65. Ma CH, Yang L, Zu YG et al (2012b) Optimization of conditions of solvent-free microwave extraction and study on antioxidant capacity of essential oil from Schisandra chinensis (Turcz.) Baill. Food Chem 134:2532–2539
66. Miao MS, Gao JL, Zhang GW et al (2009) Effect of Schisandra chinensis polysaccharide on intracerebral acetylcholinesterase and monoamine neurotransmitters in a D-galactose-induced aging brain mouse model. Neural Regener Res 4:687–693
67. Mocan A, Crişan G, Vlase L et al (2014) Comparative studies on polyphenolic composition, antioxidant and antimicrobial activities of Schisandra chinensis leaves and fruits. Molecules 19:15162–15179
68. Murashige T, Skoog F (1962) A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol Plant 15:473–497
69. Oh SY, Kim YH, Bae DS et al (2010) Anti-inflammatory effects of gomisin N, gomisin J, and schisandrin C isolated from the fruit of Schisandra chinensis. Biosci Biotechnol Biochem 74:285–291
70. Ohno T, Mikami E, Oka H (2006) Analysis of crude drugs using reversed-phase TLC/scanning densitometry. (II) Identification of ginseng, red ginseng, gentian, Japanese gentian, pueraria root, gardenia fruit, schisandra fruit and ginger. J Nat Med 60:141–145
71. Opletal L, Sovova H, Bartlova M (2004) Dibenzo[a, c]cyclooctadiene lignans of the genus Schisandra: importance, isolation and determination. J Chromatogr B 812:357–371
72. Panossian A, Wikman G (2008) Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharm 118:183–212
73. Park EJ, Chun JN, Kim SH et al (2012a) Schisandrin B suppresses TGFbeta1 signaling by inhibiting Smad2/3 and MAPK pathways. Biochem Pharmacol 83:378–384
74. Park HJ, Cho JY, Kim MK et al (2012b) Anti-obesity effect of Schisandra chinensis in 3T3-L1 cells and high fat diet-induced obese rats. Food Chem 134:227–234
75. Polish Pharmacopoeia X (2014) Schisandrae chinensis fructus Polish Pharmacopoeia Commission, Office for Registration of Medicinal Products, Medical Devices and Biocides, Warsaw
76. Quirin KW (2008) Supercritical schisandra extracts—a new concept for personal care cosmetics. Cosmet Sci Technol 1:28
77. Ramawat KG, Mathur M (2007) Factors affecting the production of secondary metabolites. In: Ramawat KG, Merillon JM (eds) Biotechnology: secondary metabolites, plants and microbes. Science Publ Inc, Jersey Plymouth, pp 59–102
78. Ren R, Ci XX, Lia HZ et al (2010) New dibenzocyclooctadiene lignans from Schisandra sphenanthera and their proinflammatory cytokine inhibitory activities. Z Naturforsch 65:211–218
79. Sa F, Zhang LQ, Chong CM et al (2015) Discovery of novel anti-parkinsonian effect of schisantherin A in in vitro and in vivo. Neurosci Lett 593:7–12
80. Saunders RMK (2000) Monograph of Schisandra (Schisandraceae). Systematic Botany Monographs, vol. 58. American Society of Plant Taxonomists, Ann Arbor, Michigan
81. Schwarzinger C, Kranawetter H (2004) Analysis of the active compounds in different parts of the Schisandra chinensis plant by means of pyrolysis-GC/MS. Monatshefte fűr Chemie 135:1201–1208
82. Shi YM, Wang LY, Zou XS et al (2014a) Nortriterpenoids from Schisandra chinensis and their absolute configurational assignments by electronic circular dichroism study. Tetrahedron 70:859–868
83. Shi YM, Zhong WM, Chen H et al (2014b) New lignans from the leaves and stems of Schisandra chinensis and their anti-HIV-1 activities. Chin J Chem 32:734–740
84. Slanina J, Páchniková G, Carnecká M et al (2014) Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition. J Nat Prod 77:2255–2263
85. Smíšková A, Vlašínová H, Havel I (2005) Somatic embryogenesis from zygotic embryos of Schisandra chinensis. Biol Plant 49:451–454
86. Song QY, Jiang K, Zhao QQ et al (2013) Eleven new highly oxygenated triterpenoids from the leaves and stems of Schisandra chinensis. Org Biomol Chem 11:1251–1258
87. Sovová H, Opletal L, Bártlová M et al (2007) Supercritical fluid extraction of lignans and cinnamic acid from Schisandra chinensis. J Supercrit Fluid 42:88–95
88. State Pharmacopoeia of the Russian Union of Soviet Socialist Republic (1990) Pharmacopoeia Committee, Ministry of Health, Moscow
89. Sun D, Lang WX, Li HB et al (2013a) An improve method for somatic embryogenesis of Schisandra chinensis (Turcz.) Baillon. Pak J Biol Sci 16:127–134
90. Sun H, Wu F, Zhang A et al (2013b) Profiling and identification of the absorbed constituents and metabolites of schisandra lignans by ultra-performance liquid chromatography coupled to mass spectrometry. Biomed Chromatogr 27:1511–1519
91. Szopa A, Ekiert H (2011) Lignans in Schisandra chinensis in vitro cultures. Pharmazie 66:633–634
92. Szopa A, Ekiert H (2012) In vitro cultures of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine)—a potential biotechnological rich source of therapeutically important phenolic acids. Appl Biochem Biotechnol 166:1941–1948
93. Szopa A, Ekiert H (2013) Production of deoxyschizandrin and γ-schizandrin in shoot-differentiating and undifferentiating callus cultures of Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine). J Biotechnol 165:209–213
94. Szopa A, Ekiert H (2014) Schisandra chinensis (Turcz.) Baill. (Chinese magnolia vine) in vitro cultures. In: Govil JN (ed) Recent progress in medicinal plants. Biotechnology and genetic engineering II, vol 39. Studium Press LLC, Houston, pp 405–434
95. Szopa A, Ekiert H (2015) Production of schisantherin A and gomisin G in in vitro cultures of Schisanda chinensis. Phytochem Let 11:440–444
96. Szopa A, Ekiert R, Ekiert H (2012) Cytryniec chiński (Schisandra chinensis)—nowy farmakopealny gatunek: badania chemiczne, biologiczna aktywność, znaczenie lecznicze, walory kosmetyczne, metody analityczne oraz badania biotechnologiczne. Farm Pol 68:832–843
97. Szopa A, Ekiert H, Kisiel W et al (2015) Isolation of three dibenzocyclooctadiene lignans from in vitro cultures of Schisandra chinensis (Turcz.) Baill.—the first report. Pharmazie 70:337–339
98. Szopa A, Kokotkiewicz A, Marzec-Wróblewska U et al (2016a) Accumulation of dibenzocyclooctadiene lignans in agar cultures and in stationary and agitated liquid cultures of Schisandra chinensis (Turcz.) Baill. Appl Microbiol Biotechnol 100:3965–3977
99. Szopa A, Kwiecień I, Ekiert H (2016b) Biotransformation of hydroquinone and 4-hydroxybenzoic acid in Schisandra chinensis (Chinese magnolia vine) in vitro cultures. (unpublished)
100. Thandavarayan RA, Giridharan VV, Arumugam S et al (2015) Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling. PLoS One 10:e0119214
101. The Japanese Pharmacopoeia (2006) Committee of the Japanese Pharmacopoeia Evaluation and Licensing Division Pharmaceuticals and Food Safety Bureau Ministry of Health, Labour and Welfare, Tokyo
102. The Korean Pharmacopoeia (2002) Central Pharmaceutical Affairs Council, Seoul
103. The Pharmacopoeia of the People’s Republic of China (2005) Chinese Pharmacopoeia Commission, Chemical Industry Press, Beijing, 2005
104. Tian K, Qi S, Cheng Y et al (2005) Separation and determination of lignans from seeds of Schisandra species by micellar electrokinetic capillary chromatography using ionic liquid as modifier. J Chromatogr A 1078:181–187
105. Tong H, Zhao B, Du F et al (2012) Isolation and physicochemical characterization of polysaccharide fractions isolated from Schisandra chinensis. Chem Nat Compd 47:969–970
106. United States Pharmacopeia–National Formulary (1999) Pharmaceutical Compounding-Sterile Products, Rockville, US Pharmacopeial Convention
107. Upton R, Petron C (1999) Schisandra berry; Schisandra chinensis, Analytical, quality control and therapeutic monograph. In: American Herbal Pharmacopeia, Santa Cruz
108. Upton R, Graff A, Jolliffe G et al (2011) American Herbal Pharmacopoeia, botanical pharmacognosy–microscopic characterization of botanical medicines. CRC Press, Boca Raton
109. Waiwut P, Shin MS, Yokoyama S et al (2012) Gomisin A enhances tumor necrosis factor-α-induced G1 cell cycle arrest via signal transducer and activator of transcription 1-mediated phosphorylation of retinoblastoma protein. Biol Pharm Bull 35:1997–2003
110. Wan CK, Tse AK, Yu ZL et al (2010) Inhibition of cytochrome P450 3A4 activity by schisandrol A and gomisin A isolated from Fructus Schisandrae chinensis. Phytomedicine 17:702–705
111. Wang C, Xu HQ (2008) Diphenyl dimethyl bicarboxylate in the treatment of viral hepatitis, adjuvant or curative. Gastroenterol Res 1:2–7
112. Wang K, Song W, Tong Y (1991) Identification of Schisandra by TLC-densitometry. China J Chin Materia Med 125:70–71
113. Wang YH, Qiu C, Wang DW et al (2011) Identification of multiple constituents in the traditional Chinese medicine formula Sheng-Mai San and rat plasma after oral administration by HPLC-DAD-MS/MS. J Pharm Biomed Anal 54:1110–1127
114. Wang JR, Kurtán T, Mándi A et al (2012) Structure and absolute stereochemistry of nortriterpenoids from Schisandra chinensis (Turcz.) Baill. Eur J Org Chem 28:5471–5482
115. Wang QY, Deng LL, Liu JJ et al (2015) Schisanhenol derivatives and their biological evaluation against tobacco mosaic virus (TMV). Fitoterapia 101:117–124
116. Wei B, Li Q, Fan R et al (2013) UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in normal and insomniac rats brain microdialysates and homogenate samples: towards an in-depth study for its sedative-hypnotic activity. J Mass Spectrom 48:448–458
117. Winston D, Maimes S (2007) Adaptogens: herbs for strength, stamina, and stress relief. Healing Arts Press, Rochester
118. World Health Organization (2007) WHO monographs on selected medicinal plants, vol 3. Fructus Schisandrae. Geneva, pp 296–313
119. Wu ZY, Raven PH, Hong DY (2008) Flora of China, vol 7. Science Press, Beijing
120. Xia YG, Yang BY, Kuang HX (2015) Schisandraceae triterpenoids: a review. Phytochem Rev 14:155–187
121. Xiao B, Liu X, Hu D et al (2007) Pharmacognostical study of Folium Schisandrae chinensis. Asian J Tradit Med 2:198–201
122. Xu L, Grandi N, Del Vecchio C et al (2015) From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors. J Microbiol 53:288–293
123. Xue YB, Zhang YL, Yang JH et al (2010) Nortriterpenoids and lignans from the fruit of Schisandra chinensis. Chem Pharm Bull 58:1606–1611
124. Yan T, Hu GS, Wang AH et al (2014) Characterisation of proanthocyanidins from Schisandra chinensis seed coats by UPLC-QTOF/MS. Nat Prod Res 28:1834–1842
125. Yang JL, Niu YD, Yang CP et al (2011) Induction of somatic embryogenesis from female flower buds of elite Schisandra chinensis. Plant Cell Tiss Organ Cult 106:391–399
126. Yim SY, Lee YJ, Lee YK et al (2009) Gomisin N isolated from Schisandra chinensis significantly induces anti-proliferative and pro-apoptotic effects in hepatic carcinoma. Mol Med Report 2:725–732
127. Zhang H, Zhang G, Zhu Z et al (2009) Determination of six lignans in Schisandra chinensis (Turcz.) Baill. Fruits and related Chinese multiherb remedies by HPLC. Food Chem 115:735–739
128. Zhang C, Zhao X, Mao X et al (2014a) Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep behaviors in mice. Eur J Pharmacol 744:157–163
129. Zhang J, Chen J, Liang Z et al (2014b) New lignans and their biological activities. Chem Biodivers 11:1–54
130. Zhang YB, Wang LH, Zhang DY et al (2014c) Ultrasound-assisted extraction and purification of schisandrin B from Schisandra chinensis (Turcz.) Baill seeds: optimization by response surface methodology. Ultrason Sonochem 21:461–466
131. Zhao T, Mao G, Mao R et al (2013) Antitumor and immunomodulatory activity of a water-soluble low molecular weight polysaccharide from Schisandra chinensis (Turcz.) Baill. Food Chem Toxicol 55:609–616
132. Zhong S, Nie YC, Gan ZY et al (2015) Effects of Schisandra chinensis extracts on cough and pulmonary inflammation in a cough hypersensitivity guinea pig model induced by cigarette smoke exposure. J Ethnopharmacol 165:73–82
133. Zhou Y, Huang SX, Pu JX et al (2011) Ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometric procedure for qualitative and quantitative analyses of nortriterpenoids and lignans in the genus Schisandra. J Pharm Biomed Anal 56:916–927
134. 2 extraction of Schisandra chinensis. Zhong Yao Cai 37:2016–2018
135. Zhu L, Li B, Liu X et al (2014b) Purification of two triterpenoids from Schisandra chinensis by macroporous resin combined with high-speed counter-current chromatography. J Chromatogr Sci 52:1082–1088
136. Zhu L, Li B, Liu X et al (2015) Purification of six lignans from the stems of Schisandra chinensis by using high-speed counter-current chromatography combined with preparative high-performance liquid chromatography. Food Chem 186:146–152